Results 1 to 10 of about 31,699 (207)

Kinetics of Sulbactam Hydrolysis by β-Lactamases, and Kinetics of β-Lactamase Inhibition by Sulbactam

Antimicrobial Agents and Chemotherapy, 2017
Sulbactam is one of four β-lactamase inhibitors in current clinical use to counteract drug resistance caused by degradation of β-lactam antibiotics by these bacterial enzymes. As a β-lactam itself, sulbactam is susceptible to degradation by β-lactamases.
Adam Shapiro
exaly   +2 more sources

Cefoperazone/sulbactam

Reactions Weekly
  +4 more sources

Meropenem/colistin versus meropenem/ampicillin–sulbactam in the treatment of carbapenem-resistant pneumonia

Journal of Comparative Effectiveness Research, 2018
Hossein Khalili, Alireza Abdollahi
exaly  

Sulbactam/Durlobactam

Clinical Therapeutics
openaire   +2 more sources

In vitro activities of β-lactam antibiotics alone and in combination with sulbactam against Gram-negative bacteria

International Journal of Antimicrobial Agents, 2004
Fu-Der Wang, Cheng-Yi Liu
exaly  

Sulbactam-based therapy for Acinetobacter baumannii infection: a systematic review and meta-analysis

Brazilian Journal of Infectious Diseases, 2013
Minggui Wang, Haiqing Chu
exaly  

Antimicrobial activity of cefoperazone-sulbactam tested against Gram-Negative organisms from Europe, Asia-Pacific, and Latin America

International Journal of Infectious Diseases, 2020
Helio Sader, Cecilia Carvalhaes, Mariana Castanheira   +2 more
exaly  

Cefoperazone/sulbactam

Reactions Weekly, 2019
openaire   +1 more source

Pharmacokinetic/pharmacodynamic evaluation of sulbactam against Acinetobacter baumannii in in vitro and murine thigh and lung infection models

International Journal of Antimicrobial Agents, 2014
Kazuaki Matsumoto, Yuta Yokoyama, Norifumi Morikawa   +2 more
exaly  

Sulbactam

RCSB Protein Data Bank
openaire   +1 more source